AI is reshaping biotech from discovery to clinical success: 9 Insights from the cutting edge

AI is rapidly moving from the edges of biotech into its core, reshaping how companies discover, design and de-risk new medicines. After years of investment and impressive laboratory breakthroughs, the industry is now focused on what it takes to turn computational power into approved therapies — from raising the probability of clinical success to building […] The post AI is reshaping biotech from discovery to clinical success: 9 Insights from the cutting edge appeared first on SiliconANGLE .